Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and latest CE information More Information
This activity will cover key topics of interest to stakeholders who set practice policy and will be called upon to evaluate and make decisions on issues pertaining to biosimilars.
Choose from the criteria below to find an activity that fits you best.
NOTE: If you attended the live Platinum Showcase continuing education activity titled "Technology & Technique: Reducing CLABSI in the Era of Value-Based Purchasing" that was held on September 28, 2015 during the 29th Annual Scientific Meeting of the Association for Vascular Access in Grapevine, Texas AND received CE credit (i.e. a nurse CE certificate), you are NOT allowed to also receive CE credit for this home-study activity.
Central-line associated bloodstream infection (CLABSI) is a costly and dangerous condition that causes billions of dollars in preventable healthcare costs in the U.S. annually. Because of this, the Center for Medicare and Medicaid Services (CMS) Value-Based Purchasing program is penalizing healthcare organizations who do not reduce the incidence of CLABSI in their facilities, while offering monetary rewards to the institutions that do. This activity presents the latest scientific research and vascular care protocols aimed at reducing or even eliminating CLABSI in hospitals, while also explaining current and upcoming changes in CMS reimbursement policy.
The target audience for this activity is nurses. Upon completion of this activity, participants will be able to:
Darcy Doellman, MSN, RN, CRNI, VA-BC™
Clinical Manager, Vascular Access Team
Cincinnati Children’s Hospital Medical Center
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. Darcy Doellman is a Consultant for Teleflex Medical (Arrow® International brands), and a Speaker for Genentech and Hospira, a Pfizer company. A portion of grant funds received by ProCE from Hospira will be used to compensate the faculty for this presentation.
Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include unlabeled indications. Use of drugs and devices outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.
Release Date: 11-02-2015
Expiration Date: 11-02-2017
This CE activity is jointly provided by ProCE, Inc. and Wild Iris Medical Education, Inc. This activity provides 1.0 contact hour of nurse CE credit.
Wild Iris Medical Education, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is supported by an educational grant from Hospira, a Pfizer company.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.